There is currently a drug shortage of Penicillin G benzathine injectable suspension products (Bicillin L-A®) listed on the FDA’s drug shortage webpage. The limited supply is primarily due to increased demand, and we are also aware that Penicillin G procaine has been discontinued by the manufacturer. To ensure the appropriate use of the available inventory and prioritize patient care, the CDC strongly encourages certain actions, specified in this Guidance Document for Healthcare Providers.

We appreciate your dedication and hard work in preventing and addressing syphilis cases, especially with the sudden increase. Your commitment to patient care during this drug shortage is essential to ensure optimal outcomes for those in need.